Sheffield healthcare company JRI Orthopaedics is marking the start of its 50th anniversary year with a major international conference.

Some of the biggest names in the orthopaedic community will be speaking at the inaugural Pathways Conference being held in London in October.

The independent, scientific meeting will be chaired by Prof Justin Cobb, Chair of Orthopaedics and clinical lead at Imperial College, London, and orthopaedic surgeon to HM The Queen.

It aims to explore and discuss new technologies that offer improved patient outcomes and programme sessions will cover device design, surgical approaches, revision strategy and assistive technologies such as computer navigation, robotics and 3D pre-operative planning.

The Pathways international orthopaedic conference marks the start of the 50th anniversary celebrations of multi-award winning JRI Orthopaedics.

Founded in 1969 by orthopaedic surgeon Ronald Furlong, the Sheffield-based company was the first in the world to produce a hip implant with a Hydroxyapatite coating enabling a biological bond with the patient’s bone and so the prospect of a hip for life.

Today, JRI Orthopaedics has world-class expertise in the design, development and manufacture of a portfolio of orthopaedic implants and systems which deliver first class solutions in joint reconstruction, repair and regeneration.

Jerry Agass, Chief Executive, said: “This is the first of what will be an annual conference connecting orthopaedic surgeons, researchers and manufacturers from across the world – with plans already in place to deliver the second event in Beijing in 2020.

JRI Orthopaedics is the main sponsor of the Pathways International Orthopaedic Conference which is being chaired by Prof Justin Cobb.

“For 50 years JRI Orthopaedics has been working in partnership with the best surgeons, academics and researchers. We have created a highly respected range of products that boast excellent clinical outcomes.

“We have also donated more than £12m million to our former owners, Orthopaedic Research UK, to help fund clinician education and further research into orthopaedics for the common good – of which we are enormously proud.

“Today, we are part of AK Medical Group, one of the world’s largest 3D-printed orthopaedic implant manufacturers, and we remain committed to the Furlong ethos of innovation, clinical excellence and partnership.

“Our 50th anniversary is a major milestone and an opportunity not just to celebrate the past but to set our eyes very firmly on the future. Pathways will be a part of that exciting story.”

The conference, being held at 30 Euston Square, London, has already attracted leading surgeons and researchers from the UK and, internationally, from Barcelona to Beijing.

These include Johan Witt, Consultant Orthopaedic and Trauma Surgeon at University College Hospitals, London and Prof Gunnar Flivik, an Associate Professor in the Department of Orthopaedics at Lund University, Sweden, who has written over 40 articles and is actively engaged in the study of Revision Hip Arthroplasty.

For more information about the conference and to book a place go to https://www.pathways-conference.org/index